ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706462

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706463

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706464

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706465

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

摘要:

Except for those in which oxygen binding is impaired, virtually all diseases of the red cell manifest themselves in the first instance as a loss of plasticity of the cell membrane, a property vital to movement of the erythrocyte through the microvasculature. Defects in membrane protein and abnormal permeability to ions, especially calcium, have been found to underlie such pathologic states as spherocytosis and sickle cell disease.

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706466

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

摘要:

Although the precise molecular mechanisms leading to the tissue destruction associated with acute pancreatitis remain to be elucidated, several clinically relevant etiologic factors are well recognized. Identification of the specific cause, most often chronic alcoholism, in a particular patient guides treatment that is largely supportive and anticipatory of possible complications.

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706467

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

摘要:

The neurogenic component appears to be an integral part of the“mosaic”of factors underlying chronic hypertension. Studies in many animal models have shown a critical interaction between the renin-angiotensin and the sympathetic nervous systems and have demonstrated the presence of an angiotensin-sensitive neural structure in the brain. The implications of these findings for human essential hypertension are discussed.

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706468

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

摘要:

Clinical trials of CDCA as a medical alternative to cholecystectomy were suspended in Britain in 1973 after animal studies raised questions of the agent's potential hepatotoxicity. Individual patients are still being accepted fortreatment, however, with the focus shifting to such questions as the minimal effective dose. It has, in fact, been learned that lower doses than those used elsewhere produce a satisfactory result, with fewer side effects.

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706469

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706470

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor

ISSN:2154-8331    

DOI:10.1080/21548331.1974.11706471

出版商:Taylor&Francis    

年代:1974

数据来源: Taylor